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Abstract
Background: Reduced renal excretion of uric acid plays a significant role in the development of
hyperuricemia and gout in adults. Hyperuricemia has been associated with chronic kidney disease
and cardiovascular disease in children and adults. There are limited genome-wide association studies
associating genetic polymorphisms with renal urate excretion measures. Therefore, we investigated the
genetic factors that influence the excretion of uric acid and related indices in 768 Hispanic children
of the Viva La Familia Study.
Methods: We performed a genome-wide association analysis for 24-h urinary excretion measures such
as urinary uric acid/urinary creatinine ratio, uric acid clearance, fractional excretion of uric acid, and glomerular
load of uric acid in SOLAR, while accounting for non-independence among family members.
Results: All renal urate excretion measures were significantly heritable (p <2 × 10−6) and ranged from
0.41 to 0.74. Empirical threshold for genome-wide significance was set at p <1 × 10−7. We observed a strong
association (p < 8 × 10−8) of uric acid clearance with a single nucleotide polymorphism (SNP) in zinc finger protein 446
(ZNF446) (rs2033711 (A/G), MAF: 0.30). The minor allele (G) was associated with increased uric acid clearance.
Also, we found suggestive associations of uric acid clearance with SNPs in ZNF324, ZNF584, and ZNF132
(in a 72 kb region of 19q13; p <1 × 10−6, MAFs: 0.28–0.31).
Conclusion: For the first time, we showed the importance of 19q13 region in the regulation of renal urate
excretion in Hispanic children. Our findings indicate differences in inherent genetic architecture and shared
environmental risk factors between our cohort and other pediatric and adult populations.
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Background
Renal excretion of uric acid is commonly involved in the
development of gout, hyperuricemia, and nephropathy
[1, 2]. The kidney filters freely circulating uric acid,
accounting for ~70% of total uric acid excretion from
the body [3]. The prevalence of hyperuricemia (increased
serum uric acid (SUA) concentrations) and gout are on
the rise along with other metabolic disorders such as
obesity, type 2 diabetes, and metabolic syndrome [3, 4].
Hyperuricemia and hyperuricosuria (increased urinary
uric acid (UrUA) concentrations) can lead to uric acid
nephrolithiasis [5–7]. Moreover, these two are common
multifactorial disorders that have been shown to have a
familial inheritance and further associated with progres-
sion to chronic kidney disease [4, 8, 9]. Hyperuricemia is
shown to cluster within families, heritabilities ranged from
39 to 45% in our family studies [10, 11], and twin studies
up to 80% for serum uric acid [12], 60% for renal clearance
of urate and 87% for fractional excretion of urate [13].
Uric acid is the end-product of purine metabolism,
which is secreted, filtered, and reabsorbed with the help of
specific urate transporters such as uric acid transporter-1
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protein (URAT1) and solute carrier family 2, member 9
(SLC2A9) [4, 14, 15]. Any defect in these urate
transporters, affecting the secretion and reabsorption
processes, might lead to increased concentration in blood
or reduced excretion of uric acid in the body [3, 9].
We have shown that variation in SUA concentrations
is affected by genetic factors and is also associated
with obesity and its comorbidities in Hispanic chil-
dren [11]. However, there are no extensive genetic
studies on parameters of renal urate excretion in chil-
dren. Therefore, assessing the genetic contribution to
excretion of uric acid and its related indices might
help develop methods to better understand the renal
urate excretion in children. In the present study, our
aim was to identify genetic loci contributing to renal
urate excretion measures using the genome-wide
association (GWA) approach in Hispanic children of
Viva La Familia Study (VFS).
Methods
Viva La Familia Study (VFS)
VFS was designed to identify genetic variants influencing
pediatric obesity and its comorbidities in Hispanic chil-
dren with the majority from Mexican American families.
VFS study design, recruitment, and methodology, demo-
graphic and phenotypic information have been described
in detail elsewhere [16]. All participants gave written
informed consent or assent. Institutional Review Boards
at Baylor College of Medicine and Affiliated Hospitals,
Texas Biomedical Research Institute and UNC Chapel
Hill approved the protocol for Human Subject Research.
Methods used to measure fasting blood and 24-h urinary
biochemistries are described elsewhere [11]. Availability
of the phenotypic data after calculation of urinary indi-
ces was limited to 768 children.
Urinary and other indices calculation
Urine sample was collected over a 24-h period and were
alkalized (pH around 8.0) using 0.5N NaOH during initial
dilution. The urinary indices, using serum and urinary uric
acid and creatinine, were calculated according to Perez-
Ruiz, et al. [2] with following equations:
SNP genotyping
The Illumina HumanOmni1-Quad v1.0 BeadChip marker
assays were used to genotype 1.1 million SNPs in 815 chil-
dren enrolled in VFS [17]. Genotype calls were obtained
after scanning on the Illumina BeadStation 500GX and
analyzed by using the GenomeStudio software. Genotyping
error rate was 2 per 100,000 genotypes (based on
duplicates). The average call rate for all SNPs per individual
sample was 97%. SNP genotypes were checked for
Mendelian consistency using the program, SimWalk2
[18]. The estimates of the allele frequencies and their
standard errors were obtained using SOLAR [19].
Heritability analysis
A variance components decomposition method was used
to estimate heritability of uric acid and other renal urate
excretion phenotypes. To estimate the genetic contribu-
tion to the variation in urinary indices, their heritability
was estimated in SOLAR. Total phenotypic variance can
be partitioned into its genetic and environmental com-
ponents. The fraction of total phenotypic variance (VP)
resulting from additive genetic effects (VG) is called
heritability and is denoted as h2 = VG/VP [20]. All traits
were adjusted for age, sex, their interaction effects, and
body surface area.
Genome-wide association (GWA) study of urinary uric
acid excretion measures
A total of 899,892 SNPs passed quality control and were
included in the GWA analysis. GWAS was performed
on 768 children from 260 Hispanic families including
1643 relative pairs. A measured genotype analysis
(MGA) was performed on the inverse normal trans-
formed residual traits (after regressing for covariate ef-
fects mentioned above) to minimize the non-normality
distribution of the data using SOLAR. Each SNP geno-
type was converted in SOLAR to a covariate measure
equal to 0, 1, or 2 copies of the minor alleles (or, the
weighted covariate based on imputation for missing
genotypes). These SNP covariates also were included in
the variance components mixed models for MGA [21] vs.
null models that incorporated the random effect of
kinship and fixed effects such as age, sex, their interaction
Body Surface Area BSA; m2ð Þ calculated by Dubois Equation ¼ 0:007184  Height cmð Þ0:725  Weight kgð Þ0:425
Creatinine clearance CrCl; ml=minð Þ ¼ Uv  UrCr=SrCrð Þ; Uv : 24−hr urine volume=time; UrCr : urinary creatinine;
SrCr : serum creatinine
Uric acid clearance UACl; ml=minð Þ ¼ Uv  UrUA=SrUAð Þ; UrUA : urinary uric acid; SrUA : serum uric acid
Urinary uric acid to urinary creatinine ratio ¼ UrUA=UrCr and expressed as absolute value
Fractional excretion of uric acid FEUA; %ð Þ ¼ UrUA  SrCrð Þ= SrUA  UrCrð Þ  100
Glomerular load of uric acid GLUA; mg=min=m2ð Þ ¼ CrCl  SrUA
Excretion of uric acid per volume of glomerular filtration EUAGF; mg=dL=m2ð Þ ¼ UrUA  SrCrð Þ=UrCr
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effects, and body surface area. For the initial GWA screen,
we tested each SNP covariate independently as a 1-df like-
lihood ratio test. The linkage disequilibrium (LD) was
computed in SOLAR by using information for all geno-
typed SNPs in all individuals. The effective number of
SNPs accounting for LD was calculated by the method of
Moskvina and Schmidt [22]. The average ratio of effective
number of SNPs to the actual number obtained from
analysis of non-overlapping bins of SNPs was used to cal-
culate the genome-wide effective number of tests and thus
the significance threshold for genome-wide association.
Empirical thresholds for genome-wide significant and sug-
gestive evidence of association were based on the distribu-
tion of p-values from 10,000 simulated null GWAS (i.e.
simulations of a heritable trait with no modeled SNP co-
variate effects using the VFS pedigree and genotypes). The
threshold for significance (p < 1 × 10−7) was defined as the
cutoff for the lower 5% tails of the empirical distribution,
and the threshold for suggestive evidence (p < 1 × 10−6)
was the minimum p-value obtained not more than once
per genome scan [11, 22].
Results
General characteristics of renal urate excretion measures
The study included data from 768 Hispanic children for
the traits considered. General characteristics are given in
Table 1 for both boys and girls and the total population,
respectively. Mean age of boys and girls was approxi-
mately 12 years; body surface area (BSA) was higher
(p <0.05) for boys (mean ± sd: 1.55 ± 0.40 m2 vs. 1.47
± 0.33 m2) than girls, similar with BSA z-scores (0.33
± 0.91 vs. 0.14 ± 0.76).
Renal 24-h urate excretion measures and their descrip-
tions are given in Table 1. Creatinine clearance (CrCl),
serum uric acid (SUA), urinary uric acid (UrUA), uric
acid clearance (UACl), urinary uric acid to urinary cre-
atinine ratio (UrUA/UrCr), and glomerular load of uric
acid (GLUA) were higher in boys than girls (p <0.05).
However, urinary creatinine (UrCr), and excretion of
uric acid per volume of glomerular filtration (EUAGF)
tended to be higher in boys compared to girls; and, frac-
tional excretion of uric acid (FEUA) tended to be higher
in girls compared to boys, but did not reach statistical
significance.
Heritability estimates
Table 1 also lists the heritability estimates and corre-
sponding p-values for the phenotypes considered in
this study. All phenotypes were adjusted for covariate
effects (age, sex, age*sex, age2, age2*sex, body surface
area z-scores). Significant heritability (h2) was de-
tected for all the traits (p <2 × 10−6) and ranged from
0.41 to 0.74.
Genome-wide association analysis
Measured Genotype Analysis (MGA) was conducted
using a variance components approach in 768 VFS
Hispanic children that accounted for family kinships
(Table 2). Genome-wide significant evidence of associ-
ation was found for single nucleotide polymorphism
(SNP) rs2033711, an intronic variant, in zinc finger
protein 446 (ZNF446) on chromosome 19 with UACl
(p <8 × 10−8, minor allele frequency (MAF) = 0.30)
(Fig. 1). The effect size or the proportion of the residual
phenotypic variance accounted for by the minor allele of
Table 1 General characteristics and renal urate excretion in Hispanic children
Variable Boys (N = 397) Girls (N = 371) Total (N = 768) Heritability estimates
Mean ± SD Mean ± SD Mean ± SD h2 ± SE P value
Age, years 11.88 ± 3.24 12.02 ± 3.48 11.95 ± 3.36 - -
BSA, m2 1.55 ± 0.40* 1.47 ± 0.33* 1.51 ± 0.37 - -
BSAZ 0.33 ± 0.91* 0.14 ± 0.76* 0.24 ± 0.85 - -
UrCr, mg/dL 95.37 ± 39.53 83.86 ± 32.10 89.81 ± 36.57 0.41 ± 0.10 1.9 × 10−06
CrCl, ml/min 60.59 ± 35.11* 47.41 ± 26.20* 54.22 ± 31.80 0.52 ± 0.09 2.5 × 10−10
SUA, mg/dL 5.84 ± 1.76* 4.99 ± 1.43* 5.43 ± 1.66 0.63 ± 0.09 1.4 × 10−12
UrUA, mg/dL 15.63 ± 13.19* 13.43 ± 11.41* 14.57 ± 12.40 0.70 ± 0.05 1.1 × 10−24
UACl, ml/min 2.99 ± 2.31* 2.43 ± 1.96* 2.72 ± 2.17 0.65 ± 0.06 1.7 × 10−20
UrUA/UrCr 0.17 ± 0.11* 0.16 ± 0.11* 0.16 ± 0.11 0.73 ± 0.05 1.3 × 10−25
FEUA, % 6.02 ± 5.14 6.34 ± 6.02 6.17 ± 5.58 0.74 ± 0.05 6.7 × 10−27
GLUA, mg/min/m2 3.63 ± 2.64* 2.33 ± 1.46* 3.00 ± 2.25 0.57 ± 0.09 2.2 × 10−11
EUAGF, mg/dL/m2 0.33 ± 0.30 0.30 ± 0.31 0.32 ± 0.31 0.73 ± 0.05 6.1 × 10−25
*p-value is significantly different at <0.05 between boys and girls; BSA body surface area, BSAZ body surface area z-scores, UrCr urinary creatinine, SUA serum uric
acid, UrUA urinary uric acid, UACl uric acid clearance, UrUA/UrCr urinary uric acid to urinary creatinine ratio, FEUA fractional excretion of uric acid, GLUA glomerular
load of uric acid, EUAGF excretion of uric acid per volume of glomerular filtration. All traits for heritability analyses adjusted for age, sex, age*sex, age^2, age^2*-
sex, body surface area z-scores; p-value <0.05 considered statistically significant
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the SNP was 4.5%. Genotype-specific means of this SNP
showed that minor allele (G) was associated with in-
creased UACl. In addition to ZNF446, a 72 kb region of
chromosome 19q13 containing several zinc finger protein
(ZNF) genes (ZNF324, ZNF584 and ZNF132) showed sug-
gestive association with UACl (Fig. 2 & Additional file 1:
Table S1), but after accounting for linkage disequilibrium
(LD; r2 < 0.80) only ZNF446 and ZNF584 and an insulin
receptor-related receptor (INSRR) gene on chromosome
1q21-23 showed evidence of suggestive association with
UACl (Table 2).
A total of 7 SNPs were found to be suggestively
(p <1 × 10−6) associated with one or the other renal
urate excretion measures with MAFs ranging from
0.01 to 0.43, and the effect size ranged from 3.1 to
4.9%, respectively. After 19q13, another notable region
where either GLUA or CrCl exhibited suggestive asso-
ciation was with a 13q12 SNP in ankyrin repeat domain
20 family, member A19, pseudogene (ANKRD20A19P).
The genotype-specific mean values and the direction of
associations (for minor alleles) of the SNPs in the genes
associated with renal urate excretion measures from
GWAS are shown in Table 3. For all UACl associated
SNPs, the minor allele was associated with elevated
UACl, except for rs10908521 on chromosome 1
(Additional file 2: Figure S1).
Table 2 Results of genome-wide association analyses of renal urate excretion measures in Viva Hispanic children
SNP Phenotype Chr Pos (GRCh38) p (SNP) β SE Effect size (%) MAF Gene symbol
rs2033711 UACl 19 58487983 7.9 × 10−08 0.32 0.06 4.5 G (0.30) ZNF446
rs10908521 UACl 1 56843858 3. 0 × 10−07 −0.35 0.07 4.3 G (0.21) INSRR
rs10423138 UACl 19 58416935 9. 4 × 10−07 0.29 0.06 3.7 G (0.31) ZNF584
rs9874872 UrUA/UrCr 3 31467743 1.8 × 10−07 −0.38 0.07 4.7 A (0.18)
rs1353327 UrUA/UrCr 3 31461468 6. 8 × 10−07 −0.49 0.10 4.1 A (0.10)
rs17079585 CrCl 13 23921903 2. 5 × 10−07 −1.53 0.30 4.0 A (0.007) ANKRD20A19P
rs4889855 FEUA 17 80539480 2. 7 × 10−07 −0.29 0.06 4.9 G (0.43)
rs17079585 GLUA 13 23921903 5. 7 × 10−07 −1.30 0.26 4.0 A (0.007) ANKRD20A19P
SNP single nucleotide polymorphism, Chr Chromosome, Pos position in base pairs, p(SNP) p-value <1 × 10−7 shows evidence of significant association, p <1 × 10−6
shows evidence of suggestive association, β beta coefficient of the SNP, SE standard error of the beta coefficient; Effect Size: proportion of the residual phenotypic
variance that is explained by the minor allele of the SNP; MAF minor allele frequency, UACl uric acid clearance, UrUA/UrCr urinary uric acid to urinary creatinine
ratio, CrCl creatinine clearance, FEUA fractional excretion of uric acid, GLUA glomerular load of uric acid, ZNF446, zinc finger protein 446, INSRR Insulin receptor-related
receptor, ZNF584 zinc finger protein 584, ANKRD20A19P ankyrin repeat domain 20 family, member A19, pseudogene
Fig. 1 Genome-wide scan showing significant evidence of association for uric acid clearance with variants on chromosome 19
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Discussion
This GWAS identified a set of genes encoding zinc fin-
ger proteins on chromosome 19q13 that were associated
with uric acid clearance in Hispanic children. To the
best of our knowledge, this is the first family-based
GWAS of renal urate excretion measures with promin-
ent effect sizes reported in children.
The kidney is responsible for ~70% of the excretion of
total body uric acid, and also reabsorbs about 90% of the
filtered urate, regulating circulating uric acid levels. Epi-
demiological studies have shown that optimum uric acid
levels may have antioxidant properties, however, elevated
SUA and UrUA levels are associated with hypertension,
inflammation, and also with kidney stones [3, 7, 23, 24].
A urate-transporting molecular complex (urate transpor-
tome) has been proposed as a model for urate transport
in renal proximal tubules since several membrane
proteins seem to be involved in urate transport [25].
According to this model, the mechanism of uric acid
transport cannot be understood by evaluating one or
two transporters. It has to be investigated as a func-
tional unit comprising of all uric acid transporters and
other molecules. This is because the renal handling of
urate transport involves several genes (e.g., solute car-
rier family 2, member 9 (SLC2A9) and ATP-binding
cassette ABC, subfamily G, member 2 (ABCG2), solute
carrier family 16, member 9 (SLC16A9), solute carrier
family 17, members 1, 3 and 4 (SLC17A1, SLC17A3
and SLC17A4), and, solute carrier family 22, members
11 and 12 (SLC22A11 and SLC22A12), most of which
have been implicated in the regulation of urate levels
[26–29].
Fig. 2 Locus Zoom plot showing the most significant SNPs on chromosome 19q13
Table 3 Genotypic class specific mean values for top SNPs from genome-wide association analyses of renal urate excretion
measures
SNP Trait Chr Major/Major Major/Minor Minor/Minor Direction of Changea
rs2033711 UACl 19 2.17 ± 1.79 2.79 ± 2.19 3.48 ± 2.69 ↑
rs10908521 UACl 1 2.86 ± 2.28 2.06 ± 1.66 1.86 ± 1.34 ↓
rs10423138 UACl 19 2.18 ± 1.78 2.77 ± 2.17 3.38 ± 2.68 ↑
rs9874872 UrUA/UrCr 3 0.18 ± 0.12 0.13 ± 0.10 0.11 ± 0.08 ↓
rs1353327 UrUA/UrCr 3 0.17 ± 0.11 0.11 ± 0.09 0.14 ± 0.13 ↓
rs17079585 CrCl 13 54.26 ± 32.25 22.47 ± 14.47 - ↓
rs4889855 FEUA 17 7.22 ± 6.01 5.88 ± 5.74 4.34 ± 3.76 ↓
rs17079585 GLUA 13 3.02 ± 2.28 1.28 ± 0.77 - ↓
aDirection of associations for minor alleles of the SNPs in the genes associated with renal handling measures from GWAS; Chr chromosome, UACl uric acid clearance,
UrUA/UrCr urinary uric acid to urinary creatinine ratio, CrCl creatinine clearance, FEUA fractional excretion of uric acid, GLUA glomerular load of uric acid
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Defects in the tubular secretion of uric acid are mainly in-
volved with urate clearance, hyperuricemia and gout [2].
Tubular secretion and reabsorption of urate levels change
dynamically with age [9]. Genetic disorders have been indi-
cated in the prevalence of hyperuricemia with increased
urinary uric acid levels, which eventually lead to the forma-
tion of kidney stones and are often associated with chronic
kidney disease [7, 30, 31]. Studies have demonstrated in
adults that renal excretion of uric acid is under considerable
genetic influence [32]. Our results indicated that all renal
urate excretion measures are heritable and are within simi-
lar range of heritabilities reported in twin adults, [13] and
Chinese twin children and adolescents [12].
Our GWAS findings on chromosome 19 revealed
genes that have not been linked to renal urate handling
before. We observed a strong genome-wide significant
association of UACl with rs2033711 in ZNF446. Add-
itionally, we found suggestive association of UACl with
ZNF584 genetic variant (rs10423138), not in LD with
rs2033711 (ZNF446) suggesting that these genetic vari-
ants are independently influencing variation in UACl.
The ZNF family is one of the major human gene families
and comprises of several of the currently recognized
transcription factors. ZNFs through the zinc finger
motifs are shown to interact with nucleic acids and are
involved in various molecular mechanisms, cell differen-
tiation and development [33, 34]. Studies indicate that
ZNF446 is a novel member of Kruppel-related family,
and believed to be one of the conserved proteins during
human evolution. Also, ZNF446 gene is highly expressed
in adult tissue cells (muscle), and may function as a
transcriptional repressor in cellular growth and develop-
ment [34, 35]. It is known to inhibit transcriptional
activities of serum response element (SRE) activator pro-
tein 1(AP-1) [34]. Interestingly, AP-1 is a cis regulatory
element regulating ABCG2 expression, one of the main
uric acid transporter [36].
Moreover, strong association of UACl with ZNF446
itself is interesting because studies have shown associ-
ation of ZNF365, on chromosome 10, with urolithiasis
in children, [7] and with uric acid nephrolithiasis in
adults [5, 37]. However, our results indicate a different
pattern of zinc finger protein involvement in uric acid
metabolism compared with adult studies [5, 7, 37]. The
functional relevance of these genes with uric acid
involvement is largely unknown, except that the
emergence of ZNF365 variants is correlated with
disappearance of uricase in primate evolution and
hence causing a predisposition to hyperuricemia in
humans [5, 37].
We found suggestive association of rs4889855 on
chromosome 17 (Gene not identified) with FEUA. How-
ever, in adults, FEUA was shown to be associated with
genetic variants of glucokinase regulator (GCKR on
chromosome 2), SLC2A9 and ABCG2 on chromosome 4,
and insulin like growth factor 1 receptor (IGF1R on
chromosome 15) [38]. We also found suggestive evi-
dence of association between GLUA and CrCl and
ANKRD20A19P gene variant (on chromosome 13q12),
both these associations prove to be interesting as
beta-spectrin and ankyrin are key components of the
cytoskeleton membrane that regulates clustering of
sodium channel [39]. Additionally, we also found sug-
gestive association of UACl with SNPs in INSRR on
chromosome 1. Some studies have suggested func-
tional association between mRNA expression of insulin
receptor-related and insulin-like growth factor receptors
and tumor cells [40]. One GWAS study indicated a new
locus linked to chromosome 2p22.1-p21 for familial
juvenile hyperuricaemic nephropathy, [41] but none of
our associations with urinary uric acid handling have been
reported before. The relatively small sample size in this
study is a limitation. However, family-based studies have
increased power to detect associations due to the fact that
768 children generate 1643 relative pairs and the degree of
resemblance between relative pairs is considered for the
genetic analysis.
Our study in VFS children is the first to report such
genetic findings, and existing literature is limited in
children involving GWAS on renal urate excretion
measures. However, previous studies have reported
association of 19q13 region with kidney phenotypes and
diseases [42, 43]. This region has been linked to familial
nephrotic syndrome [44], focal segmental glomerularo-
sclerosis [45, 46] and cystinuria [47]. Our results are also
different from studies that have reported association of
uric acid transporters with renal uric acid excretion, for
example, ABCG2 for renal urate excretion [27], and
GCKR, SLC2A9, and IGF1R for FEUA [38], partly attribut-
able to population substructure and sample size consid-
ered as majority of the GWAS are conducted in European
or Asian descent populations. Nevertheless, our 19q13 re-
gion contains several ZNF proteins (including ZNF446)
that may be involved in transcription of specific uric acid
transporters. Thus, our GWAS associations could reflect
differences in inherent genetic architecture and shared en-
vironmental risk factors between our VFS pediatric cohort
and other study populations.
Conclusions
Our GWAS identified novel loci, particularly in 19q13,
influencing the regulation of renal excretion of uric acid
in Hispanic children. Our findings from children are not
identical with those from adults [5, 37, 38] suggesting
metabolic alterations in uric acid metabolism tracking
from childhood to adults. The majority of the GWAS
studies are conducted in adults highlighting the need for
pediatric studies investigating the genetic underpinnings
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of the variation in uric acid earlier in the life course. It is
essential to acquire knowledge on renal urate hand-
ling in children as it may reveal clinical and biological
insights regarding the pathophysiology of uric acid
excretion by the kidneys, given the inherited nature
of these disorders.
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Additional file 1: Table S1. Results of genome-wide association analysis
for uric acid clearance with variants on chromosome 19 in Viva Hispanic
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(GIF 40 kb)
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